- Home
- HSTM vs YDES Comparison
HSTM vs YDES Comparison
Compare HSTM & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HSTM | YDES |
|---|---|---|
| Founded | 1990 | 2013 |
| Country | United States | Taiwan |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 642.6M | 894.2M |
| IPO Year | 1999 | N/A |
Fundamental Metrics
Financial Performance| Metric | HSTM | YDES |
|---|---|---|
| Price | $20.94 | $7.50 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $28.00 | N/A |
| AVG Volume (30 Days) | ★ 336.8K | 9.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 0.67% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.61 | N/A |
| Revenue | ★ $304,064,000.00 | N/A |
| Revenue This Year | $8.95 | N/A |
| Revenue Next Year | $4.92 | N/A |
| P/E Ratio | $34.64 | ★ N/A |
| Revenue Growth | ★ 4.26 | N/A |
| 52 Week Low | $19.50 | $7.30 |
| 52 Week High | $34.13 | $25.00 |
Technical Indicators
Market Signals| Indicator | HSTM | YDES |
|---|---|---|
| Relative Strength Index (RSI) | 48.19 | 33.63 |
| Support Level | $19.50 | N/A |
| Resistance Level | $22.96 | $13.19 |
| Average True Range (ATR) | 0.69 | 0.52 |
| MACD | -0.06 | 0.03 |
| Stochastic Oscillator | 35.36 | 17.49 |
Price Performance
Historical ComparisonAbout HSTM HealthStream Inc.
HealthStream Inc provides workforce and provider solutions for healthcare organizations. Its reportable segments include Workforce Solutions and Provider Solutions. Workforce development solutions consist of SaaS, subscription-based products that are used by healthcare organizations. Its Provider Solutions products offer healthcare organizations software applications for administering and tracking provider credentialing, privileging, call center and enrollment activities. The company generates a majority of its revenue from Subscription Services.
About YDES YD Bio Limited Ordinary Shares
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.